Wegovy carries an additional indication for cardiovascular risk reduction in adults with obesity and established cardiovascular disease, based on outcomes from the SELECT trial
In cases requiring more intensive glucose control, insulin therapy remains an effective option, though it requires more frequent monitoring and carries a risk of hypoglycaemia and weight gain
1), and the first GLP-1 analogue brought into clinical development was liraglutide, a once-daily injection
When evaluating peptide suppliers, look for comprehensive quality documentation, transparent communication, proper storage and shipping protocols, and established reputation within the research community
This is a crucial reason why a specialist should prescribe these drugs
Next-Generation Myostatin Inhibitors: Bimagrumab, Trevogrumab, and Apitegromab Compared Introduction# The myostatin inhibition field has entered a new era